CD4/CD8 Cell Ratios in Individuals with Acute and Early HIV Infection
Martin Hoenigl, MD
Assistant Research Scientist at the Antiviral Research Center
University of California San Diego (UCSD), San Diego, CA
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Martin Hoenigl is an Assistant Research Scientist in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). Before joining UCSD in June 2014, Martin Hoenigl has been an infectious diseases and internal medicine fellow at the Medical University of Graz, Austria, with a research focus on fungal diagnostics and clinical pharmacology of antimycotic drugs. Since joining UCSD, his research focus is acute and early HIV infection and HIV prevention. He conducts translational clinical research focused on prevention and treatment of acute and very recent HIV infection, and - as a PI of two recently funded projects (CFAR Developmental Grant and TMARC pilot study) and an IRFN trainee – an increasing focus on NeuroAIDS. To date, he is author to 101 Pub Med listed publications in the field of infectious diseases, the majority in leading authorship roles.
At the completion of this educational session, learners will:
- Know that low CD4/CD8 ratios in HIV infection are associated with higher risk of non-AIDS-related morbidity and mortality.
- Understand the dynamic of CD4/CD8 ratios during acute and early HIV infection.
- Appreciate how immediate/early ART initiation may positively influence this dynamic, and reduce the risk of non-AIDS morbidity and mortality.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
